WORK Medical Technology Group is trading 9.46% up in pre-market at $2.43 after investors reacted to its August 14, 2026 H1 results and newly reported financing plans.

  • The company disclosed approximately $2.125 million in private-placement proceeds for expansion, working capital, and general corporate purposes.
  • The financing includes 2 million Class A shares at $1.00 and 50,000 Class B shares at $2.50; closing conditions remained unsatisfied as of the filing.
  • The catalyst appears company-specific, though limited liquidity may amplify the small-cap move.